Tertiary lymphoid structures associated with enhanced anti-tumor immunity and favorable prognosis in cervical squamous carcinoma

被引:1
作者
Xiong, Guohai [1 ,2 ]
Shan, Jinmei [1 ,2 ]
Chong, Qingguo [1 ,2 ]
Cui, Yueqing [1 ,2 ]
机构
[1] Yancheng Third Peoples Hosp, Dept Gynaecol, Yancheng 224008, Peoples R China
[2] Nanjing Med Univ, Dept Gynaecol, Yancheng Sch Clin Med, Yancheng 224008, Peoples R China
来源
AGING-US | 2024年 / 16卷 / 08期
关键词
tertiary lymphoid structures; anti-tumor immunity; cervical cancer; prognosis; B-CELLS; IMMUNOTHERAPY; LANDSCAPE; REVEAL;
D O I
暂无
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Background: Cervical squamous carcinoma (CESC) is the main subtype of cervical cancer. Unfortunately, there are presently no effective treatment options for advanced and recurrent CESC. Tertiary lymphoid structures (TLSs) are clusters of lymphoid cells that resemble secondary lymphoid organs; nevertheless, there is no summary of the clinical importance of TLS in CESC. Methods: A large set of transcriptomic and single-cell RNA-sequencing (scRNA-seq) datasets were used to analyze the pattern of TLS and its immuno-correlations in CESC. Additionally, an independent in-house cohort was collected to validate the correlation between TLS and TME features. Results: In the current study, we found that the presence of TLS could predict better prognosis in CESC and was correlated with the activation of immunological signaling pathways and enrichment of immune cell subpopulations. In addition, TLS was associated with reduced proliferation activity in tumor cells, indicating the negative correlation between TLS and the degree of malignancy. Last but not least, in two independent immunotherapy cohorts, tumors with the presence of TLS were more sensitive to immunotherapy. Conclusion: Overall, TLS is related to an inflamed TME and identified immune-hot tumors, which could be an indicator for the identification of immunological features in CESC.
引用
收藏
页码:6898 / 6920
页数:23
相关论文
共 46 条
[1]   Mechanistic role of HPV-associated early proteins in cervical cancer: Molecular pathways and targeted therapeutic strategies [J].
Bhattacharjee, Rahul ;
Das, Sabya Sachi ;
Biswal, Smruti Sudha ;
Nath, Arijit ;
Das, Debangshi ;
Basu, Asmita ;
Malik, Sumira ;
Kumar, Lamha ;
Kar, Sulagna ;
Singh, Sandeep Kumar ;
Upadhye, Vijay Jagdish ;
Iqbal, Danish ;
Almojam, Suliman ;
Roychoudhury, Shubhadeep ;
Ojha, Shreesh ;
Ruokolainen, Janne ;
Jha, Niraj Kumar ;
Kesari, Kavindra Kumar .
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2022, 174
[2]   Spatiotemporal Dynamics of Intratumoral Immune Cells Reveal the Immune Landscape in Human Cancer [J].
Bindea, Gabriela ;
Mlecnik, Bernhard ;
Tosolini, Marie ;
Kirilovsky, Amos ;
Waldner, Maximilian ;
Obenauf, Anna C. ;
Angell, Helen ;
Fredriksen, Tessa ;
Lafontaine, Lucie ;
Berger, Anne ;
Bruneval, Patrick ;
Fridman, Wolf Herman ;
Becker, Christoph ;
Pages, Franck ;
Speicher, Michael R. ;
Trajanoski, Zlatko ;
Galon, Jerome .
IMMUNITY, 2013, 39 (04) :782-795
[3]   Understanding the tumor immune microenvironment (TIME) for effective therapy [J].
Binnewies, Mikhail ;
Roberts, Edward W. ;
Kersten, Kelly ;
Chan, Vincent ;
Fearon, Douglas F. ;
Merad, Miriam ;
Coussens, Lisa M. ;
Gabrilovich, Dmitry I. ;
Ostrand-Rosenberg, Suzanne ;
Hedrick, Catherine C. ;
Vonderheide, Robert H. ;
Pittet, Mikael J. ;
Jain, Rakesh K. ;
Zou, Weiping ;
Howcroft, T. Kevin ;
Woodhouse, Elisa C. ;
Weinberg, Robert A. ;
Krummel, Matthew F. .
NATURE MEDICINE, 2018, 24 (05) :541-550
[4]   Mature tertiary lymphoid structure is a specific biomarker of cancer immunotherapy and does not predict outcome to chemotherapy in non-small-cell lung cancer [J].
Brunet, M. ;
Crombe, A. ;
Cousin, S. ;
Vanhersecke, L. ;
Le Loarer, F. ;
Bessede, A. ;
Italiano, A. .
ANNALS OF ONCOLOGY, 2022, 33 (10) :1084-1085
[5]  
Bruno TC, 2020, NATURE, V577, DOI 10.1038/d41586-019-03943-0
[6]   Tertiary lymphoid structures improve immunotherapy and survival in melanoma [J].
Cabrita, Rita ;
Lauss, Martin ;
Sanna, Adriana ;
Donia, Marco ;
Larsen, Mathilde Skaarup ;
Mitra, Shamik ;
Johansson, Iva ;
Phung, Bengt ;
Harbst, Katja ;
Vallon-Christersson, Johan ;
van Schoiack, Alison ;
Loevgren, Kristina ;
Warren, Sarah ;
Jirstroem, Karin ;
Olsson, Hakan ;
Pietras, Kristian ;
Ingvar, Christian ;
Isaksson, Karolin ;
Schadendorf, Dirk ;
Schmidt, Henrik ;
Bastholt, Lars ;
Carneiro, Ana ;
Wargo, Jennifer A. ;
Svane, Inge Marie ;
Jonsson, Goran .
NATURE, 2020, 577 (7791) :561-+
[7]   Interferon-Induced Transmembrane Protein 3 Shapes an Inflamed Tumor Microenvironment and Identifies Immuno-Hot Tumors [J].
Cai, Yun ;
Ji, Wenfei ;
Sun, Chuan ;
Xu, Rui ;
Chen, Xuechun ;
Deng, Yifan ;
Pan, Jiadong ;
Yang, Jiayue ;
Zhu, Hongjun ;
Mei, Jie .
FRONTIERS IN IMMUNOLOGY, 2021, 12
[8]   The Gene Ontology Resource: 20 years and still GOing strong [J].
Carbon, S. ;
Douglass, E. ;
Dunn, N. ;
Good, B. ;
Harris, N. L. ;
Lewis, S. E. ;
Mungall, C. J. ;
Basu, S. ;
Chisholm, R. L. ;
Dodson, R. J. ;
Hartline, E. ;
Fey, P. ;
Thomas, P. D. ;
Albou, L. P. ;
Ebert, D. ;
Kesling, M. J. ;
Mi, H. ;
Muruganujian, A. ;
Huang, X. ;
Poudel, S. ;
Mushayahama, T. ;
Hu, J. C. ;
LaBonte, S. A. ;
Siegele, D. A. ;
Antonazzo, G. ;
Attrill, H. ;
Brown, N. H. ;
Fexova, S. ;
Garapati, P. ;
Jones, T. E. M. ;
Marygold, S. J. ;
Millburn, G. H. ;
Rey, A. J. ;
Trovisco, V. ;
dos Santos, G. ;
Emmert, D. B. ;
Falls, K. ;
Zhou, P. ;
Goodman, J. L. ;
Strelets, V. B. ;
Thurmond, J. ;
Courtot, M. ;
Osumi-Sutherland, D. ;
Parkinson, H. ;
Roncaglia, P. ;
Acencio, M. L. ;
Kuiper, M. ;
Laegreid, A. ;
Logie, C. ;
Lovering, R. C. .
NUCLEIC ACIDS RESEARCH, 2019, 47 (D1) :D330-D338
[9]   Pan-cancer Immunogenomic Analyses Reveal Genotype-Immunophenotype Relationships and Predictors of Response to Checkpoint Blockade [J].
Charoentong, Pornpimol ;
Finotello, Francesca ;
Angelova, Mihaela ;
Mayer, Clemens ;
Efremova, Mirjana ;
Rieder, Dietmar ;
Hackl, Hubert ;
Trajanoski, Zlatko .
CELL REPORTS, 2017, 18 (01) :248-262
[10]   clusterProfiler 4.0: A universal enrichment tool for interpreting omics data [J].
Wu, Tianzhi ;
Hu, Erqiang ;
Xu, Shuangbin ;
Chen, Meijun ;
Guo, Pingfan ;
Dai, Zehan ;
Feng, Tingze ;
Zhou, Lang ;
Tang, Wenli ;
Zhan, Li ;
Fu, Xiaocong ;
Liu, Shanshan ;
Bo, Xiaochen ;
Yu, Guangchuang .
INNOVATION, 2021, 2 (03)